Association of cognitive impairment, depressive symptoms and sarcopenia among healthy older men in the veterans retirement community in southern Taiwan: A cross-sectional study

Geriatrics and Gerontology International

Volumn 14, Issue SUPPL.1, 2014, Pages 102-108

  Hsu, Ying Hsin ^a,b   Liang, Chih Kuang ^a,b   Chou, Ming Yueh ^a,b   Liao, Mei Chen ^a,b   Lin, Yu Teh ^a,b   Chen, Liang Kung ^b,c   Lo, Yuk Keung ^a,b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cognitive impairment; Depressive mood; Elderly; Men; Sarcopenia

Indexed keywords

AGE; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITION; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG DEPENDENCE; GERIATRIC DEPRESSION SCALE; GERIATRIC PATIENT; GRIP STRENGTH; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MUSCLE MASS; MUSCLE STRENGTH; PRIORITY JOURNAL; RETIREMENT; SARCOPENIA; TAIWAN; VERY ELDERLY; VETERAN; WALKING SPEED;

COGNITIVE IMPAIRMENT; DEPRESSIVE MOOD; ELDERLY; MEN; SARCOPENIA;

AGED; AGED, 80 AND OVER; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEPRESSION; GAIT; GERIATRIC ASSESSMENT; HAND STRENGTH; HUMANS; INCIDENCE; MALE; MUSCLE STRENGTH; NEUROPSYCHOLOGICAL TESTS; REFERENCE VALUES; SARCOPENIA; TAIWAN; VETERANS;

EID: 84892837009     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12221     Document Type: Article

References (46)

1. Rosenberg IH. Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr 1989; 50: 1231-1233.
2. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr 1997; 127: 990S-991S.
3. Cruz-Jentoft AJ, Baeyens JP, Bauer JM etal. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412-423.
4. Abellan van Kan G. Epidemiology and consequences of sarcopenia. J Nutr Health Aging 2009; 13: 708-712.
5. Arango-Lopera VE, Arroyo P, Gutiérrez-Robledo LM, Pérez-Zepeda MU. Prevalence of sarcopenia in Mexico City. Eur Geriatr Med 2012; 3: 157-160.
6. Wang C, Bai L. Sarcopenia in the elderly: basic and clinical issues. Geriatr Gerontol Int 2012; 12: 388-396.
7. Landi F, Liperoti R, Russo A etal. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 2012; 31: 652-658.
8. Landi F, Cruz-Jentoft AJ, Liperoti R etal. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing 2013; 42: 203-209.
9. Abellan van Kan G, Cesari M, Gillette-Guyonnet S etal. Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohort. Age Ageing 2013; 42: 196-202.
10. Sastre IHRA. Exercise, Sarcopenia, Cognition, and mood. Nutr Aging 2002; 6: 151-162.
11. Johnson DK, Wilkins CH, Morris JC. Accelerated weight loss may precede diagnosis in Alzheimer disease. Arch Neurol 2006; 63: 1312-1317.
12. Buchman AS, Schneider JA, Wilson RS, Bienias JL, Bennett DA. Body mass index in older persons is associated with Alzheimer disease pathology. Neurology 2006; 67: 1949-1954.
13. Cronk BB, Johnson DK, Burns JM. Alzheimer's Disease Neuroimaging I. Body mass index and cognitive decline in mild cognitive impairment. Alzheimer Dis Assoc Disord 2010; 24: 126-130.
14. Burns JM, Johnson DK, Watts A, Swerdlow RH, Brooks WM. Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch Neurol 2010; 67: 428-433.
15. Lin CC, Lin WY, Men NH etal. Sarcopenia prevalence and associated factors in an elderly taiwanese metropolitan population (letters to the editor). J Am Geriatr Soc 2013; 61: 459-462.
16. O'Brien JT, Lloyd A, McKeith I, Gholkar A, Ferrier N. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry 2004; 161: 2081-2090.
17. 56 Ballmaier M, Toga AW, Blanton RE etal. Anterior cingulated, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients an MRI-based parcellation of the prefrontal cortex. Am J Psychiatry 2004; 161: 99-108.
18. Vogelzangs N, Kritchevsky SB, Beekman AT etal. Obesity and onset of significant depressive symptoms: results from a prospective community-based cohort study of older men and women. J Clin Psychiatry 2010; 71: 391-399.
19. Lee JSW, Auyeung T-W, Kwok T, Lau EMC, Leung P-C, Woo J. Associated factors and health impact of sarcopenia in older Chinese men and women: a cross-sectional study. Gerontology 2007; 53: 404-410.
20. Chang CH, Chou MY, Chou SL etal. Risk factors for frequent emergency department visits of veterans home residents in Northern Taiwan. J Clin Gerontol Geriatr 2012; 3: 118-121.
21. Liu HC, Lin KN, Teng EL etal. Prevalence and subtypes of dementia in Taiwan: a community survey of 5297 individuals. J Am Geriatr Soc 1995; 43: 144-149.
22. Liao CY, Yeh YZ, Ke HZ. Geriatric depression scale (GDS) - a preliminary report of reliability and validity for Chinese version. Changhua Med J 1995; 1: 11-17.
23. D.P. FBES. Refining a casemix measure for nursing homes. Resource Utilisation Groups (RUG-III). Med Care 1994; 32: 668-685.
24. Liu LK, Lee WJ, Liu CL etal. Age-related skeletal muscle mass loss and physical performance in Taiwan: implications to diagnostic strategy of sarcopenia in Asia. Geriatr Gerontol Int 2013; 13: 964-971.
25. Wu SW, Wu SF, Liang HW, Wu ZT, Huang S. Measuring factors affecting grip strength in a Taiwan Chinese population and a comparison with consolidated norms. Appl Ergon 2009; 40: 811-815.
26. Chien MY, Huang TY, Wu YT. Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc 2008; 56: 1710-1715.
27. Tangalos EG, Smith EG, Ivnik RJ etal. The Mini-Mental State Examination in general medical practice: clinical utility and acceptance. Mayo Clin Proc 1996; 71: 829-837.
28. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992; 40: 922-935.
29. Sheikh JIY, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol 1986; 5: 165-173.
30. Liang CK, Chen LK, Tsai CF etal. Screening depression among institutionalized older Chinese men by minimum data set: we need a new instrument. J Geriatr Psychiatry Neurol 2011; 24: 179-183.
31. Fried LP, Tangen CM, Walston J etal. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146-M156.
32. Lee WJ, Liu LK, Peng LN, Lin MH, LK C, Group IR. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study. J Am Med Dir Assoc 2013; 14: 528.e1-528.e7.
33. Takechi H, Sugihara Y, Kokuryu A etal. Both conventional indices of cognitive function and frailty predict levels of care required in a long-term care insurance program for memory clinic patients in Japan. Geriatr Gerontol Int 2012; 12: 630-636.
34. Auyeung TW, Kwok T, Lee J, Leung PC, Leung J, Woo J. Functional decline in cognitive impairment-the relationship between physical and cognitive function. Neuroepidemiology 2008; 31: 167-173.
35. Burns JM, Johnson DK, Watts A etal. Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch Neurol 2010; 67: 428-433.
36. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life disease and frailty. Annu Rev Med 2000; 51: 245-270.
37. Beyer I, Mets T, Bautmans I. Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care 2012; 15: 12-22.
38. Licastro F, Pedrini S, Caputo L etal. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1 antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain. J Neuroimmunol 2000; 103: 97-102.
39. Siu PM, Pistilli EE, Alway SE. Age-dependent increase in oxidative stress in gastrocnemius muscle with unloading. J Appl Physiol 2008; 105: 1695-1705.
40. Meng SJ, Yu LJ. Oxidative stress, molecular inflammation and sarcopenia. Int J Mol Sci 2010; 11: 1509-1526.
41. Mangialasche F, Polidori MC, Monastero R etal. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Res Rev 2009; 8: 285-305.
42. Kim NH, Kim HS, Eun CR etal. Depression is associated with sarcopenia, not central obesity, in elderly korean men. J Am Geriatr Soc 2011; 59: 2062-2068.
43. Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M. Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract 2009; 15: 289-305.
44. Maggio M, Lauretani F, Ceda GP. Sex hormones and sarcopenia in older persons. Curr Opin Clin Nutr Metab Care 2013; 16: 3-13.
45. Sakuma K, Yamaguchi A. Sarcopenia and age-related endocrine function. Int J Endocrinol 2012; 2012: 1-10.
46. Hwang AC, Liu LK, Lee WJ etal. Association of androgen with skeletal muscle mass and muscle function among men and women age 50 years and older in Taiwan: results from I-Lan Longitudinal Aging Study. Rejuvenation Res 2013; 16: 453-459.